Smith & Nephew Grants Nil‑Cost RISE Share Plan Awards to Senior Leadership
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Smith & Nephew Snats ( (SNN) ).
On 15 April 2026, Smith & Nephew plc granted awards of US$0.20 ordinary shares under its RISE Share Plan, part of the wider Restricted Share Plan 2024, to a group of senior executives classified as persons discharging managerial responsibilities. The nil‑cost awards, disclosed on 16 April 2026 under UK Market Abuse Regulation, align leadership incentives with shareholder interests and reinforce the company’s RISE strategy, but do not involve on‑market trades or immediate cash consideration for stakeholders.
The most recent analyst rating on (SNN) stock is a Hold with a $35.00 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
The score is driven primarily by improving financial performance (margin and cash flow rebound) and supportive technicals (price above major moving averages with positive momentum). Valuation is only average at a 22.7 P/E, while the earnings call adds confidence via upbeat 2026 growth/profit guidance but flags meaningful near-term tariff and reimbursement headwinds.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Smith & Nephew plc is a UK‑based medical technology company best known for its orthopaedics, sports medicine, and advanced wound management products. Listed in the U.S. as a foreign private issuer, it targets global healthcare markets with a focus on surgical devices and related solutions for hospitals and clinicians worldwide.
Average Trading Volume: 859,202
Technical Sentiment Signal: Strong Buy
Current Market Cap: $14.61B
Find detailed analytics on SNN stock on TipRanks’ Stock Analysis page.
